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Chromatin Protamination and 
Catsper Expression in Spermatozoa 
Predict Clinical Outcomes after 
Assisted Reproduction Programs
S. Marchiani1, L. Tamburrino1, F. Benini2, L. Fanfani2, R. Dolce1, G. Rastrelli  3, M. Maggi3,  
S. Pellegrini2 & E. Baldi1
Identification of parameters predicting assisted reproductive technologies (ARTs) success is a major 
goal of research in reproduction. Quality of gametes is essential to achieve good quality embryos and 
increase the success of ARTs. We evaluated two sperm parameters, chromatin maturity and expression 
of the sperm specific calcium channel CATSPER, in relation to ART outcomes in 206 couples undergoing 
ARTs. Chromatin maturity was evaluated by Chromomycin A3 (CMA3) for protamination and Aniline 
Blue (AB) for histone persistence and CATSPER expression by a flow cytometric method. CMA3 
positivity and CATSPER expression significantly predicted the attainment of good quality embryos 
with an OR of 6.6 and 14.3 respectively, whereas AB staining was correlated with fertilization rate. 
In the subgroup of couples with women ≤35 years, CATSPER also predicted achievement of clinical 
pregnancy (OR = 4.4). Including CMA3, CATSPER and other parameters affecting ART outcomes (female 
age, female factor and number of MII oocytes), a model that resulted able to predict good embryo 
quality with high accuracy was developed. CMA3 staining and CATSPER expression may be considered 
two applicable tools to predict ART success and useful for couple counseling. This is the first study 
demonstrating a role of CATSPER expression in embryo development after ARTs programs.
Infertility is a condition of global proportion affecting about 15% of couples1, expected to increase in the future. 
Assisted reproduction technologies (ARTs) are a valid and widely used treatment option for couple infertility. 
Although huge improvements in outcomes of ARTs have been made in the last few years, the successful preg-
nancy rate remains quite low, averaging, in European countries, 29.6% for in vitro fertilization (IVF) and 27.8% 
for intracytoplasmic sperm injection (ICSI)2. Lack of ART success implicates financial burden on both health 
services and patients and impacts negatively on life quality of couples. Failures in ART can be attributed to embry-
onic factors, as embryo quality plays a crucial role in the attainment of pregnancy3. Currently, no reliable markers 
are available to predict embryo quality and other early ART outcomes, which are related directly to the quality 
of the couple gametes. At present, male gamete assessment is based on semen analysis which is poorly predictive 
of both natural4 and assisted5,6 reproduction, as the semen of about 20–30% of normozoospermic men has low 
fertilizing ability7. Indeed, beside normal motility and morphology, a spermatozoon must have intact DNA and 
other essential features to be able to fertilize the oocyte and to allow a correct embryo development. Since iden-
tification/assessment of molecular markers of oocyte quality is basically unfeasible, the identification of sperm 
markers able to predict ART outcomes represents a priority to reduce negative psychological and economic con-
sequences to the couples. In the present study, we focused on chromatin maturity status and expression of the 
calcium channel CATSPER, two essential features for correct sperm function.
During spermatogenesis histones are replaced by protamines to stabilize chromatin structure8. Such pro-
cess allows organizing sperm DNA into a tightly packed structure to preserve paternal genome during the tran-
sit in male and female genital tracts until the interaction with the oocyte. Although about 15% of histones are 
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physiologically retained by spermatozoa, a greater persistence of histones or a decreased protamination are an 
index of chromatin immaturity that can affect sperm quality and the fertilizing capacity9. Among the tests used to 
evaluate sperm chromatin compaction, Chromomycin A3 (CMA3) and Aniline Blue (AB) stainings are two sim-
ple, low cost and easy to perform methods. CMA3 competes with protamines for binding to DNA minor groove 
representing an indirect measure of protamination state. AB staining assesses the histone persistence by binding 
to lysine residues of these nuclear proteins. Although several studies10,11 evaluated the impact of chromatin com-
paction on ARTs, the heterogeneity of the ART outcomes taken into account and the lack of consideration of pos-
sible confounding factors such as female age and female infertility factors, do not allow to draw clear conclusions 
about the predictive ability of this parameter. Indeed, it is known that female age is an important predictor of ART 
success, in particular, the probability of pregnancy decreases markedly after the age of 35 years12,13. Similarly, 
some female infertility causes (i.e. poor ovarian reserve, endometriosis and polycystic ovary syndrome) are asso-
ciated with reduced chance of fertilization, implantation and pregnancy in ARTs14–16. Another key limiting factor 
in female fertility is oocyte maturation, determined by the acquisition of a series of competencies during follicular 
development which allow reaching the metaphase II (MII) stage17.
Studies on animal models highlighted the key role of the sperm-specific calcium channel CATSPER (Cationic 
Channel of Sperm) in the development of hyperactivated motility18–20, an essential sperm characteristic. The 
functional channel is formed by four homologous subunits (CATSPER 1–4) and at least three auxiliary subu-
nits21,22. In the mouse, Qi et al.19 demonstrated that lack of any CATSPER subunits leads to complete absence of 
the channel in mature spermatozoa. Recently, we demonstrated a positive correlation between the level of expres-
sion of CATSPER1 subunit (measured by a flow cytometric method23,24) and sperm number, progressive motility 
and hyperactivation24, suggesting that expression of the channel may be indicative of sperm quality. On the other 
hand, the few men with deletions in CATSPER subunits genes, leading to absence of a functional channel in sper-
matozoa, are infertile and show poor semen quality25,26. However, until now, it is unknown whether CATSPER 
expression is implicated in human fertilization process or related to ART outcomes.
We here assessed chromatin maturity status (by CMA3 and AB staining) and CATSPER1 expression (by a 
flow cytometric method) in semen samples from male partners of 206 couples undergoing ART treatments. To 
determine if these male molecular markers may be predictive of ART success, it was evaluated their association 
with ART outcomes, both as single test and in combination, taking into account several confounding factors 
affecting the statistical analysis.
Results
Chromatin compaction and ART outcomes. Age and semen parameters values of the male partners of 
the 206 couples included in the study are shown in Table 1. None of the semen parameters evaluated on the day 
of pick up nor male age were related to early ART outcomes, pregnancy achievement or delivery (not shown). In 
addition, semen parameters on the day of pick up were similar in groups with EQA <50% or ≥50%, FR <80% or 
≥80% and in couples achieving or not clinical pregnancy or ending or not with delivery (Table 1), confirming lack 
or poor predictivity of ART outcomes by semen parameters. The median percentages of spermatozoa showing 
chromatin immaturity revealed by AB (n = 163) and CMA3 (n = 149) techniques were 20.0% [13.0–28.0] and 
23.0% [16.0–33.5], respectively. The two measures were significantly correlated (r = 0.5, p < 0.0001, n = 147). 
Correlations between levels of CMA3 and AB staining and ART outcomes are reported in Table 2. The percentage 
of CMA3 positive spermatozoa resulted negatively associated with EQA (Table 2) even after adjusting for female 
age, female factor and number of MII oocytes (adj. β = −0.2, p = 0.04). No significant correlations were found 
between CMA3 and other ART outcomes. After categorizing couples according to the percentage of embryos with 




Women age FR EQA Pregnancy Delivery
≤35(n = 115) >35 (n = 91) p <80% (n = 89)
≥80%  

































































































































































Table 1. Median [IQR range] values of male age and semen parameters in male partners of infertile couples 
included in our study. Semen parameters were evaluated on the day of insemination in all subjects except 
morphology which was evaluated in 106 subjects. p: probability; ns: not significant; FR: fertilization rate; EQA: 
embryos with A quality.
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(EQA <50%: 23.0 [16.5–34.5], n = 133; EQA ≥50%: 12.0 [8.5–22.0], n = 9, p = 0.005, Fig. 1A, middle panel). The 
difference was confirmed in a confounder-adjusted model (p = 0.02). To establish a CMA3 value able to predict 
an EQA ≥50%, ROC analysis was performed (Fig. 1A, lower panel). At a threshold of 19.5%, CMA3 predicted 
the attainment of EQA ≥50% with 78% sensitivity and 65% specificity. Applying a logistic regression model, we 
found that the probability of obtaining EQA ≥50% was higher when the CMA3 positivity was ≤19.5% (OR = 6.6, 
CI 95%: 1.29–33.63, p = 0.02).
AB positivity was negatively associated with FR (Table 2 and Fig. 1B, middle panel), even in a confounder-adjusted 
model (adj. β = −0.2, p = 0.02). No correlation was observed with other ART outcomes (Table 2). To determine the 
accuracy of AB in predicting the FR, we used ROC as a binary classifier system choosing a value of 80% FR, which 
corresponds to median value of the cohort (Fig. 1B, lower panel). At a threshold of 25.5%, AB predicted FR ≥80% with 
a good sensitivity (78%) but low specificity (41%) (Fig. 1B, lower panel). A post hoc binary logistic regression analysis 
indicated that the probability of obtaining an FR ≥80% was higher when the AB positivity was ≤25.5%, with an OR of 
2.3 (CI 95%: 1.19–4.79, p = 0.01).
To further investigate whether female age affects the association between CMA3 and AB positivity and ART 
outcomes, a subgroup analysis was performed according to women age ≤35 or >35 years (the median age of 
our cohort and the threshold above which the risk of miscarriage and chromosomal aberrations significantly 
increase27,28 and the probability of pregnancy decreases12,13). In couples with women ≤35 years (n = 115), the 
subgroup analysis confirmed the significant difference in CMA3 positivity between EQA <50% and EQA ≥50% 
(not shown) as well as the correlation between AB positivity and FR (not shown) found in the entire cohort. In 
addition, the OR to predict the achievement of an EQA ≥50% for CMA3 threshold of 19.5 increased to 10.7 (CI 
95%: 1.78–97.74, p = 0.04), and the OR to obtain an FR ≥80% for the AB threshold of 25.5% to 2.8 (CI 95%: 
1.12–6.95, p = 0.03).
CATSPER1 expression and ART outcomes. In the 141 male partners of the cohort, the median value 
of CATSPER1 expression was 4.5 [3.5–5.8]. At a first glance, CATSPER1 expression was found to be correlated 
with no ART outcome (not shown). However, after adjustment for female age, female factor and number of MII 
oocytes, a positive correlation between CATSPER1 expression and EQA was unmasked (adj. β = 0.2, p = 0.03). 
Figure 2B shows that CATSPER1 MFI was significantly higher in the group with EQA ≥50% (5.3 [4.3–6.9, n = 16] 
in EQA ≥50% vs 4.3 [3.4–5.6, n = 120] in EQA <50%, p = 0.002). The difference was also confirmed after adjust-
ing for confounders (p = 0.03). A ROC curve analysis was performed to determine the threshold of CATSPER1 
expression associated with EQA ≥50% (Fig. 2C). We found that the attainment of a good embryo quality was 
predicted with a specificity of 91% and a sensitivity of 44% at the CATSPER1 value of 6.74. By binary logistic 
regression, we found that above this threshold (CATSPER1 ≥6.74) the OR to obtain an EQA ≥50% was 14.3 (CI 
95%: 3.50–58.09; p < 0.0001).
In the subgroup of younger women (≤35 years), CATSPER1 expression was significantly correlated with 
EQA, IR and PR (Table 3), even after adjusting for female factor and number of MII oocytes (EQA: adj. β = 0.3, 
p = 0.005; IR: adj. β = 0.3, p = 0.03; PR: adj. β = 0.2, p = 0.05). As in the entire cohort, CATSPER1 MFI was higher 
in couples with EQA ≥50% (6.8 [4.5–7.2, n = 9] vs 4.1 [3.4–5.3, n = 64] in EQA <50%, p = 0.006), even in a 
confounder-adjusted model, p = 0.02. In addition, in this subgroup, CATSPER1 expression was higher in cou-
ples achieving clinical pregnancy (5.2 [3.7–6.8, n = 20] vs 4.05 [3.2–5.1, n = 45] in the non-pregnant, p = 0.02; 
Fig. 2D). This difference was confirmed after adjusting for female factor and number of MII oocytes (p = 0.05). 
CATSPER expression was also slightly, but not significantly, higher in couples ending with a delivery (median val-
ues: 5.9 [3.7–6.9, n = 13] vs 4.6 [3.6–6.4, n = 7], p = ns). Logistic regression analysis showed that when CATSPER1 
MFI was ≥6.74 (see above) the odds to obtain EQA ≥50% (OR = 17.7, CI 95%: 3.07–102.07, p = 0.001) and to 
achieve clinical pregnancy (OR = 4.4, CI 95%: 1.08–18.21, p = 0.04) were higher.
Development of an Embryo quality prediction model. The results concerning the ability of both 
CMA3 and CATSPER1 levels to predict EQA ≥50% prompted us to build up an embryo quality prediction model. 
As mentioned above, embryo quality is considered, indeed, as a strong predictor of implantation, pregnancy and 
live birth after ARTs3,13,29,30. In particular, in our cohort, couples with an EQA ≥50% had 3.17 higher probability 
of pregnancy (CI 95%: 1.04–9.62, p = 0.04). Considering previously published studies regarding the clinical sig-
nificance of female parameters on ART outcomes, the model not only included CMA3 positivity and CATSPER1 
ART outcome
Total cohort
CMA3 (%) AB (%)
FR r = −0.05, p = 0.6, n = 149 r = −0.2, p = 0.004, n = 163
CR r = −0.01, p = 0.9, n = 145 r = −0.02, p = 0.7, n = 159
EQA r = −0.2, p = 0.03, n = 142 r = −0.02, p = 0.8, n = 156
IR r = 0.01, p = 0.9, n = 124 r = 0.02, p = 0.8, n = 138
PR r = 0.03, p = 0.7, n = 124 r = 0.1, p = 0.4, n = 138
DR r = −0.04, p = 0.4, n = 40 r = 0.2, p = 0.2, n = 45
Table 2. Correlations between sperm AB or CMA3 positivity and ART outcomes (FR, CR, EQA, IR, PR and 
DR) in the total cohort of couples. FR: Fertilization rate; CR: Cleavage rate; EQA: embryos with A quality; IR: 
Implantation rate; PR: Pregnancy rate; DR: Delivery rate. r: Spearman’s correlation coefficient, p: probability, n: 
number of couples.
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expression, but also female age12,13, female factor14–16 and number of MII oocytes17. Table 4 reports coefficients 
from the logistic regression model that could be used to calculate a probability of obtaining an EQA ≥50% for all 
couples. The equation describing the probability of developing good embryos is:
= ÷ +e eP (1 )x x
with x = b0 + b1*p1 + b2*p2 + b3*p3 + b4*p4+b5*p5, where p1…p5 are our predictors’ values and b0…b5 are 
the coefficients derived from the model (Table 4). We assessed the discrimination of the predictive model by 
Figure 1. Association between CMA3 or AB and ART outcomes. (A) upper panel: Examples of spermatozoa 
positive (a) or not (b) after staining with CMA3; middle panel: Box plot representing sperm CMA3 positivity 
in the two groups with embryos with A quality (EQA) <50% (n = 133) and ≥50% (n = 9); lower panel: Receiver 
Operating Characteristic curve of the ability of CMA3 positivity to predict the attainment of at least 50% 
EQA. (B) upper panel: Examples of spermatozoa positive (a) or not (b) after staining with AB; middle panel: 
Association between sperm AB positivity and FR. Note that statistical analyses have been performed using FR 
as a continuous variable, even if grouped in quartiles for graphical purposes; lower panel: Receiver Operating 
Characteristic curve of the ability of AB positivity to predict the attainment of at least 80% FR. *p ≤ 0.05; FR: 
Fertilization rate; EQA: embryos with A quality; AUC: Area under the curve; CI: confidence interval.
www.nature.com/scientificreports/
5SCIENTIFIC REPORTS | 7: 15122  | DOI:10.1038/s41598-017-15351-3
calculating the area under the ROC curve (Fig. 3), which denotes that our model is able to predict the achieve-
ment of an EQA ≥50% with good probability. The goodness of fit of the model was evaluated using the Hosmer–
Lemeshow statistic test. Such test demonstrated no statistically significant difference between the predicted and 
observed values (x² = 3.107, p = 0.927).
Figure 2. Association between CATSPER1 expression and embryo quality and pregnancy achievement. (A) 
Typical histogram of CATSPER1 fluorescence in spermatozoa showing overlay of test sample (open) and 
corresponding negative control (rabbit serum, grey). (B) Images obtained by fluorescence microscopy and 
relative bright field of spermatozoa stained with CATSPER1 antibody (left) or rabbit serum (right). (C) Box 
plot representing CATSPER1 expression in groups with embryo quality A (EQA) <50% (n = 120) and ≥50% 
(n = 16). (D) Receiver operating characteristic curve of the ability of CATSPER1 MFI to predict the attainment 
of at least 50% EQA. E: Box plot representing CATSPER1 expression in couples achieving (n = 20) or not 
(n = 45) clinical pregnancy in the subpopulation of couples with female partners ≤35 years. *p ≤ 0.05; AUC: 
Area under the curve; CI: confidence interval; MFI: median fluorescence intensity.
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Discussion
Despite the considerable progresses done in the latest years, the rate of clinical pregnancy after ARTs remains 
low (about 30%). The identification of one or more parameters able to predict the outcomes of ARTs appears 
mandatory to increase the percentage of success, avoid psychological stress, optimize the correct counselling of 
the couples and reduce the costs. Among the critical steps for ART success, the development of a good quality 
embryo appears of upmost importance, as it is highly related to the attainment of clinical pregnancy, as demon-
strated in the current and previous studies3. We show here that two sperm parameters, chromatin compaction 
as evaluated by CMA3 staining and expression of the sperm specific calcium channel subunit CATSPER1, show 
significant correlations with development of good quality embryos, suggesting a certain grade of dependence of 
embryo quality from the two parameters. Based on the evaluation of the two sperm parameters, and including 
ART outcome
Female age ≤ 35 years
CATSPER1 (MFI)
FR r = −0.1, p = 0.2, n = 74
CR r = 0.05, p = 0.7, n = 74
EQA r = 0.2, p = 0.05, n = 73
IR r = 0.3, p = 0.02, n = 63
PR r = 0.3, p = 0.01, n = 63
DR r = 0.14, p = 0.6, n = 19
Table 3. Correlations between CATSPER1 expression and ART outcomes (FR, CR, EQA, IR, PR and DR) in 
the subpopulation of couples with female partners ≤ 35 years. FR: Fertilization rate; CR: Cleavage rate; EQA: 
embryos with A quality; IR: Implantation rate; PR: Pregnancy rate; DR: Delivery rate. r: Spearman’s correlation 
coefficient, p: probability, n: number of couples.
Covariates Coefficient SE p-value CI 95%
CMA3 (%) b1:–0.178 0.070 0.012 0.730 0.961
CATSPER1 (MFI) b2:0.971 0.357 0.007 1.311 5.318
Number of MII oocytes b3:0.174 0.131 0.183 0.921 1.537
Female age b4:–0.002 0.197 0.991 0.681 1.474
Female factor b5:–1.536 1.297 0.236 0.017 2.734
Constant b0:–5.458 7.139 0.444
Table 4. Binary logistic regression model to predict embryo quality type A. SE: standard error; CI: confidence 
interval; P-value probability.
Figure 3. Predictive model of embryo quality. Receiver operating characteristic curve of the probability 
of obtaining a percentage of embryo quality of type A ≥50% as predicted by the proposed binary logistic 
regression model described in the text. AUC: area under the ROC curve; CI: confidence interval.
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other parameters that are known to affect embryo quality, we developed a model which resulted able to predict 
the ability of couples to obtain good quality embryos with high accuracy. In addition, we demonstrated that 
expression of CATSPER1 unveils the importance of sperm quality in pregnancy achievement in couples with 
female age below 35 years.
In our study, chromatin maturity status has been assessed by two methods, CMA3 and AB, which are widely 
described in the literature10,11. Theoretically the two methods should evaluate the same sperm aspect and, indeed, 
a positive relationship is present between the results obtained with the two techniques (31–32 and present study). 
However, the correlation is not as tight as expected (r = 0.5 in the present study and 0.4 in the Iranpour et al.31 
study), suggesting that histones retention (evaluated by AB) does not necessarily correspond to a decrease of 
protamination (evaluated by CMA3) and vice versa. Such conclusion is strengthened by the demonstration that 
CMA3 and AB results are differently related to ART outcomes (present study and refs31,33). In particular, we found 
that whereas CMA3 values are associated to the development of good quality embryos, AB staining is only weakly 
associated with fertilization rate.
Our data on the association between CMA3 positivity and embryo quality is in apparent contrast with two 
previous studies, where such correlation was not observed34,35. Of note, the latter studies were conducted on a 
small number of couples and without considering female factor and/or female age34 or simply excluding female 
factors from the analysis35. We now show not only that CMA3 predicts achievement of EQA ≥50% in the entire 
cohort, but also that the OR for this prediction is almost twice higher in couples with younger women. This sug-
gests that women age could mask the sperm contribution to embryo development and evidences the necessity of 
considering female age and female factors in the analysis on the impact of sperm characteristics on ARTs results. 
Protamines are important actors in the fertilization process: they are exchanged for maternal nucleosomes shortly 
after fertilization36 and this process may be important for reprogramming to totipotency of the zygote37.
At difference with other studies31–33,38,39 we did not observe any relationship between CMA3 and fertilization 
rate, probably because of the high FR obtained in our study (about 80%). However, a negative relationship with 
FR was observed for AB staining, suggesting that the chromatin status may impact the ability of spermatozoa 
to fertilize the oocyte. It appears from our study that histones persistence, rather than protamination, is more 
important in the fertilization process. Other groups did not find any associations between sperm AB staining and 
ART outcomes probably due to the small number of included couples31,32,40. Further studies are needed to better 
understand the role of histone persistence in fertilization.
Overall our results remark the importance of chromatin maturation for ART success. On the other hand, an 
incorrect chromatin compaction exposes spermatozoa to DNA damage41 which can impact ART outcomes42–44. 
With regard to most assays assessing sperm DNA fragmentation, the tests detecting chromatin immaturity used 
in our study are easy and rapid to perform, require a low number of cells and no technologically advanced instru-
ments, hence they could be performed in any ART centre. All these advantages make CMA3 and AB methods 
valuable tools to support routine semen analysis in the diagnosis of male partner of infertile couples.
The present study is the first one evaluating the association between CATSPER1 protein expression (likely 
reflecting the expression of the entire CATSPER channel19) and ART outcomes. A role of CATSPER channel 
in sperm-oocyte interaction is expected since KO mice for any CATSPER subunit are infertile19 because their 
spermatozoa are unable to develop hyperactivated motility and to penetrate the zona pellucida. In addition, men 
with mutations/deletions in genes encoding for CATSPER subunits show fertility problems26 likely due to absence 
of a functional channel25. In human spermatozoa CATSPER is activated with a non-genomic mechanism45 by 
progesterone46,47, a hormone present in high concentrations at fertilization site, by a rise of intracellular pH, such 
as induced by 4-aminopyridine48, and by other components present in follicular fluid49. Sperm responsiveness 
to both progesterone and 4-aminopyridine are correlated to fertilization rate in ART programs48,50,51. We found 
here that CATSPER1 expression levels are higher in couples with good embryo quality in the entire cohort and 
in couples achieving clinical pregnancy in the subgroup of young women. Most importantly, we demonstrate 
that, at the threshold of ≥6.74 MFI, CATSPER1 expression predicts development of good embryos with an OR 
of 14.3. This result indicates that a higher expression of the channel in sperm is important for a correct human 
embryo development. However, whether CATSPER channel is indicative of a sperm characteristic implicated in 
embryo development or is required itself for the process is presently unknown. In a previous paper by our group 
we demonstrated that the percentage of human spermatozoa expressing CATSPER1 predicts with high accuracy 
the sperm ability to hyperactivate24, suggesting that the channel is involved in the capacitation process leading 
to hyperactivation in vitro. It has been demonstrated that spermatozoa of CATSPER KO mice partially reacquire 
the ability to fertilize the oocyte by in vitro fertilization and to develop blastocysts when capacitation is acceler-
ated by the addition of the calcium ionophore A23187, evidencing a crucial role of CATSPER in capacitation52. 
Recently, in bovine, it has been demonstrated that artificial induction of capacitation is important for blastocyst 
formation also when fertilization is obtained with ICSI53. Capacitation is essential for mammalian male fertility, 
as demonstrated by several KO models where the process is impaired54,55. Interestingly, Navarrete et al.52 showed 
that artificial induction of capacitation in some of these models (including, as mentioned above, CATSPER) 
restores the fertilizing ability of spermatozoa in vitro. We speculate that a higher CATSPER1 expression leads to 
a higher degree of capacitation of spermatozoa which is important for embryo development. Whereas the reason 
why lack of capacitation can affect fertilization competence in in vitro fertilization is understandable (lack of 
hyperactivated motility, inability to respond to acrosome reaction stimuli), why it might influence embryo devel-
opment is obscure. Capacitated spermatozoa show many features that may affect oocyte activation and embryo 
development56, including elevated intracellular calcium levels57, tyrosine phosphorylation of proteins58,59, and 
modifications of the extracellular membrane composition60. Lack or low CATSPER expression may result in 
alteration of capacitation-related sperm calcium balance that could impact on oocyte activation. A recent study 
demonstrated that sperm expression of the protein PAWP is associated with embryo development in couples 
undergoing ICSI61 although, also in this case, the mechanisms involved in such action are poorly defined. Of note, 
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a recent study demonstrated the importance of the sperm calcium channel TRP-3 in mediating the calcium wave 
occurring at fertilization in C. elegans oocyte62. To assess the role of CATSPER channel during fertilization and 
embryo development further studies are necessary in animal models.
The involvement of CATSPER1 expression in EQ is reinforced by our results within the younger women sub-
group, where the same parameter was associated with and predicted pregnancy achievement with an OR of 4.4. 
The association between CATSPER1 and pregnancy achievement could simply reflect the higher embryo quality 
obtained in subjects with higher CATSPER1 expression. The relationship between CATSPER1 and pregnancy is 
observed in the subgroup with younger women, where the probability of pregnancy is higher and the contribu-
tion of male factor is likely unmasked.
None of the sperm parameters evaluated in our study were related to delivery rate. It should be considered that 
there are many factors that may influence a term pregnancy and the birth of a healthy child, some of which could 
be independent from the fact that clinical pregnancy has been obtained by ARTs.
Since both CMA3 and CATSPER1 are able to discriminate between low and high quality embryos, we intro-
duced these markers in a model including also female parameters (female age, female factor and number of MII 
oocytes) in order to ameliorate the prediction value of EQA. The probability of developing a good quality embryo, 
derived from such model, results more accurate than the single parameters. Moreover, in the present study, the 
predictive and observed values did not differ, confirming the reliability of the model. Several prediction models 
focusing on embryo quality, clinical pregnancy or live births (using IVF or ICSI) as primary outcome are present 
in the literature. Such studies include female factors (age, causes of infertility, hormone levels etc.) and/or general 
couple data (history and type of infertility) omitting entirely male parameters or simply considering the presence/
absence of male factor infertility63–66. To our knowledge, this is the first study to present a novel model encom-
passing both female parameters and sperm intrinsic characteristics, such as the chromatin maturity status and 
expression of CATSPER1, as available prognostic factors in prediction models for IVF/ICSI outcomes.
This study has the strength of determining the impact of chromatin immaturity and CATSPER1 expression 
on ART outcomes taking into account female age, female factor and number of MII oocytes as confounders in 
the statistical analysis in a large number of couples. The study has some limitations. In particular, CATSPER1 
expression was evaluated only in subjects with a sufficient number of spermatozoa to allow the determination (i.e. 
when it was possible to harvest 10 million spermatozoa from the entire ejaculate before selection for ARTs). Thus, 
patients with a low initial sperm number or severe male factor were not included. Since CATSPER1 expression 
is positively related with sperm number24, it is possible that subjects with low CATSPER1 expression were less 
represented in our cohort.
In conclusion, our study demonstrates that sperm histone retention plays a role in oocyte fertilization, whereas 
sperm protamine content and expression of CATSPER1 are involved in the development of good quality embryos. 
Combining the latter two markers with female age and female factor, we developed a prediction model of embryo 
quality which could be applicable in clinical practice and in the management of couples undergoing ARTs.
Materials and Methods
Study design and participants. The experimental protocol has been approved by the internal ethical com-
mittee of Demetra ART Center of Florence (Italy). We enrolled in a prospective cohort study 206 consecutive 
couples undergoing ART cycles at the Demetra ART Center of Florence (Italy) from March 2015 to October 
2016. The obtainment of an informed written consent from the couples was the only criterion for inclusion in the 
study. All the couples were informed that, after the normal clinical practice for the ART treatment, the eventual 
remaining semen or selected spermatozoa would be used for the study.
The infertility diagnosis was: 56% female factor, 18% male factor, 10% male and female factor in combination 
and 16% unexplained. 156 couples were treated with ICSI and 50 with IVF. In 30 couples it was not possible 
to perform fresh transfer. Indications for deferred embryo transfer were: risk of ovarian hyperstimulation syn-
drome67, elevated progesterone levels (≥1.5 ng/ml) and inadequate endometrium on the trigger day68 in 20, 4 
and 6 cases, respectively. To avoid a potential confounding bias due to different embryo transfer (fresh or frozen), 
implantation rate, pregnancy rate and delivery rate were calculated only for fresh embryo transfer (176/206). We 
transferred 1 embryo in 45 cases (26%), 2 in 124 (70%) and 3 in 7 (4%).
The median age of subjects was 35 [23–43] and 38 [27–55] years for female and male partners, respectively.
Ovarian stimulation, IVF, ICSI, and Embryo Development. All the patients were treated accord-
ing to the standard ovarian stimulation protocols of the clinic: 1) midluteal-phase GnRH-agonist (triptore-
lin, Decapeptyl, Ipsen Pharma) long protocol, followed by gonadotropin stimulation; 2) follicular phase 
GnRH-agonist/flare protocol (triptorelin, Decapeptyl, Ipsen Pharma), started with gonadotropin stimulation; 3) 
short protocol including gonadotropin stimulation from day 2 of the cycle, combined with a flexible antagonist 
protocol (cetrorelix 0.25 mg/day Cetrotide, Merck Serono or ganirelix 0.25 mg, Orgalutran, MSD Italia). In all 
cases follicle stimulation was performed with individual dosage of recombinant follicle stimulating hormone r–
FSH (Gonal F, Merk Serono or Puregon, MSD Italia) or of highly purified human menopausal gonadotropin hMG 
(Meropur, Ferring), with a starting dose ranging from 150 to 450 IU, according to age, body mass index, ovarian 
reserve index and response to previous ovarian stimulation. The dose was then modified according to the ovarian 
response (determined by serum estradiol levels and ultrasound evaluation at 2 days interval), until at least two 
follicles reached 17 mm in mean diameter. Finally, oocytes maturation was induced by injection of 5000 IU of 
u-hCG (Gonasi, Ibsa Farmaceutici Italia) or 250 µg r-hCG (Ovitrelle, Merck Serono).
Gonadotropin stimulation and GnRH-agonist or GnRH-antagonist was continued until the day of hCG trig-
gering, when progesterone levels were measured. Oocytes retrieval was performed about 35 hours later by sono-
graphically guided puncture of the follicles, under sedation and local anesthesia.
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For IVF, undecumulated oocytes were incubated overnight with about 50.000 spermatozoa/oocyte in 
Continuous Single Culture® Complete medium (Irvine Scientific, Santa Ana, CA, USA). For ICSI, Nikon Eclipse 
TE2000-S microscope equipped with Narishige IM-9B Microinjector was used. After 18 ± 1 hours from insem-
ination (IVF) or after 17 ± 1 hours from microinjection (ICSI), oocytes were assessed for 2 pro-nuclei presence.
Continuous Single Culture® Complete medium was used for embryo culture. After 24 ± 1, 44 ± 1 and 
68 ± 1 hours, pace of division, degree of fragmentation, size and symmetry of the blastomeres were evaluated 
by Nikon Eclipse TE2000-S microscope (Nikon, Tokyo, Japan). Embryos were incubated in a MINC benchtop 
incubator (Cook Medical, Bloomington, USA) at 37 °C, 6% CO2 and 5% O2 and were scored according to the cri-
teria detailed in Supplementary Fig. 1. Embryos showing the best properties were classified into A class. Embryos 
showing slight deviation in the degree of fragmentation (5–30%), symmetry and division pace were classified 
into B and B/C (Supplemental Fig. 1). More considerable deviations were the cause for classifying them into 
C and D. Degenerated or arrested embryos (type E) were not transferred. Surplus transferable embryos were 
cryopreserved.
After 3 days post oocyte retrieval, embryos were transferred into the uterus.
Luteal support was given to all patients, administered as intravaginal micronized progesterone (Progeffik, 
200 mg three times daily, EFFIK Italia), from the day after oocyte pick up until 12 days after embryo transfer, 
when serum hCG was measured. In case of positive hCG levels, clinical pregnancy was verified by ultrasound 
about 15 days later.
Sperm preparation. Semen samples were collected by masturbation after 2–7 days of abstinence on the day 
of oocyte insemination. Sperm number, progressive motility and morphology were evaluated after liquefaction at 
37 °C, according to WHO criteria69. Briefly, sperm number was evaluated by improved Neubauer chamber after 
appropriate dilution, motility by Nikon Eclipse TE2000 microscope scoring at least 100 spermatozoa/slide and 
morphology after Diff-Quick staining69. Sperm selection for oocyte insemination was performed by swim up (95 
samples) or density gradient centrifugation (111 samples), according to sample characteristics. Swim up was per-
formed by washing seminal fluid with Sperm Wash Medium (Irvine, Santa Ana, CA, USA) supplemented with 1% 
human serum albumin (HSA), and centrifuging at 300 g for 10 min. The obtained pellet was gently layered with 
1 ml of the same medium and incubated at 37 °C. After 45 min, 800 µl of the upper medium phase was collected.
Density gradient centrifugation was performed layering 1 ml semen samples on 1 ml 45% and 90% strati-
fied PureSperm (Nidacon, Gothenberg, Sweden) fractions (prepared in Sperm Wash Medium /HSA medium) 
and centrifuged at 300 g for 10 min at room temperature (RT). The resulting pellet was collected and trans-
ferred to separate test tubes. Then, each fraction was washed with 1 ml of Sperm Wash/HSA medium and then 
re-suspended in the same medium.
After selection, the obtained fraction was checked for sperm count and motility, kept at 37 °C in the same 
medium and used to inseminate the oocytes within 15 minutes from selection.
Sperm chromatin immaturity. Sperm chromatin immaturity was evaluated in selected spermatozoa 
remaining after oocyte insemination by AB (n = 149) and CMA3 (n = 163) staining.
After sperm selection and fixation in paraformaldehyde [PFA, 500 µL, 4% in phosphate-buffered saline (PBS) 
pH 7.4, for 30 min at RT], 4 × 105 spermatozoa were stained with 100 µL of CMA3 (Sigma Aldrich, St Louis, MO, 
USA) solution [0.25 mg/mL in McIlvane’s buffer (0.2 M Na2HPO4, 0.1 M citric acid), pH 7.0, containing 10 mM 
MgCl2], for 20 min at RT in the dark. Cells were then washed and resuspended in 10 µL of McIlvane’s buffer, pH 
7.0, containing 10 mM MgCl2, smeared on slide, air-dried and mounted with PBS: glycerol (1:1). Two hundred 
spermatozoa were analyzed on each slide by fluorescence microscope (Axiolab A1 FL; Carl Zeiss, Milan, Italy), 
equipped with Filter set 49 and an oil immersion 100x magnification objective. Two types of staining patterns 
were identified: bright green fluorescence of the sperm head (abnormal chromatin packaging) and weak green 
staining (normal chromatin packaging) (Fig. 1A)70.
AB staining, which selectively stains lysine-rich histones71 was performed as previously described70. Briefly, 
after fixation in 4% PFA, 1 × 105 spermatozoa were smeared on slide, air-dried and then stained with 5% aque-
ous AB (Sigma Aldrich, St Louis, MO, USA) mixed with 4% acetic acid (pH 3.5) for 5 min72 at RT. Two hundred 
spermatozoa were analyzed on each slide under a light microscope (Leica DM LS; Leica, Wetzlar, Germany). 
Spermatozoa showing dark-blue staining were considered as AB positive (Fig. 1B)72.
Detection of CATSPER1. The extent of CATSPER1 expression in spermatozoa was determined in whole 
semen (n = 141) remaining after sperm preparation for ART, by an immunofluorescence-flow cytometric 
method, as previously described23,24. 10 × 106 unselected spermatozoa were fixed in 4% PFA and washed twice 
in 1% NGS (normal goat serum, Sigma Aldrich, St Louis, MO, USA)-PBS, before permeabilization with 0.1% 
Triton X-100 in 100 µL 0.1% sodium citrate for 4 min in ice. After splitting into three identical aliquots, sperm 
samples were incubated for 1 hour at RT either with anti-CATSPER1 antibody (4 µg/ml, test sample, Santa Cruz 
Biotechnology, Dallas, TX, USA) or normal rabbit serum (4 µg/ml, Signet Laboratories, Hayward, CA, USA), the 
latter for negative control. The samples were washed twice in 1% NGS- PBS, and subsequently were incubated 
for 1 hour in the dark with goat anti-rabbit IgG-FITC (Southern Biotech, Birmingham, AL, USA) diluted 1:100 
in 1% NGS-PBS. After two washing procedures, spermatozoa were resuspended in 300 µL PBS and incubated in 
the dark for 15 min at RT with 4.5 µL Propidium Iodide (PI, 50 µg/ml in PBS) to stain the nuclei. The third aliquot 
of spermatozoa was prepared with the same procedure but omitting the PI staining, for instrumental compen-
sation. Samples were acquired using a flow cytometer (FACScan, Becton Dickinson, Mountain View, CA, USA) 
equipped with a 15-mW argon ion laser used at 488 nm for excitation. Green fluorescence of FITC-conjugated 
goat anti-mouse IgG was revealed by an FL-1 (515–555-nm wavelength band) detector; red fluorescence of PI was 
detected by an FL-2 (563–607-nm wavelength band) detector. We acquired 8000 nucleated events (i.e. the events 
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stained with PI) in the gate of the characteristic forward scatter/side scatter region of sperm cells73. CATSPER1 
expression in the different samples was expressed as median fluorescence intensity (MFI), calculated by the ratio 
between the median intensity of cells of the test sample and the median intensity of cells of the corresponding 
negative control (a fluorescence histogram depicting a negative control and a test sample is shown in Fig. 2A). 
Spermatozoa stained with the anti-CATSPER1 antibody used in our experiments were observed using Axiolab A1 
FL (Carl Zeiss, Milan, Italy) fluorescence microscope using an oil immersion 100x magnification objective. The 
staining reveals a patchy and punctate pattern in the tail of most CATSPER positive spermatozoa (Fig. 2B)23,24.
Statistical analysis. The following ART outcomes were considered: fertilization rate (FR, number of fer-
tilized oocytes/number of inseminated oocytes); cleavage rate (CR, number of embryos/number of fertilized 
oocytes); good embryo quality (EQA, number of embryos of A quality/number of total embryos); implantation 
rate (IR, number of gestational sac with fetal heart beat/number of transferred embryos); pregnancy rate (PR, 
number of clinical pregnancy/number of transferred embryos) and delivery rate (DR, number of delivery/num-
ber of clinical pregnancy).
Data were analyzed with SPSS (Statistical Package for the Social Sciences, Chicago, IL, USA), version 24.0 for 
Windows. Continuous variables that were found to be not normally distributed after the Kolmogorov-Smirnov 
test were expressed as median (interquartile range- IQR) value. Considering that no statistically significant dif-
ferences were observed between IVF and ICSI for each outcome (not shown), the analysis was conducted in the 
entire cohort. Correlations were assessed using Spearman’s methods and Mann–Whitney U test was used for 
comparisons between groups. Multivariate analysis was performed to adjust data for confounding factors known 
to influence ART outcomes, such as female age12,13, female factors14–16 and number of MII oocytes17. For female 
factors only poor ovarian reserve, endometriosis and polycystic ovary syndrome were considered as, in ARTs, all 
other female factors are overcome by embryo transfer.
We used receiver operating characteristic (ROC) curve analysis to test the accuracy (as area under the curve, 
AUC) with 95% confidence interval, the sensitivity and the specificity, as well as to identify cut-off values of the 
different sperm variables (AB, CMA3 and CATSPER1) in predicting ART outcomes. Logistic regression was used 
to estimate adjusted odds ratios (OR) with 95% confidence intervals (CI).
Prediction models were constructed for those outcomes resulting correlated to one or more evaluated param-
eters. Predictors significantly associated with such outcomes were analyzed at multivariable logistic regression 
including in the model female age, female factor and number of MII oocytes as covariates. The performance of the 
models was quantified with respect to discrimination74, i.e. how the goodness of the model is able to distinguish 
between the two groups achieving or not the outcome, which was quantified with the ROC AUC. The reliability 
of the prediction produced by the model was statistically tested by the Hosmer-Lemeshow goodness-of-fit test.
All statistical tests were 2-sided, and P values of ≤0.05 were considered statistical significant.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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